INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Challenges To High-Concentration Formulation Development
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
Shifting Drug Development With Advanced Analytical Characterization
Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.
-
Rapid Delivery Of Toxicological Study Material: Accelerating Development
Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.
-
One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To Lead
Discover Curia’s cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.
-
Analytical Method Release And Stability Platform For RNA Drug Substance3/14/2025
We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.
-
Supply-Chain Statistics And Realistic Outsourcing Options3/12/2025
Kishore Hotha, President, Dr. Hotha’s Life Sciences, provides some telling stats that should inform outsourcing decision-making in the coming months… and perhaps years.
-
Remind Me: Why Are We At Biotech War With China?3/12/2025
It’s hard to focus on the issues that precipitated the challenges and proscribed solutions to so much of our supply chain being in China. IP was (and should be) at the center of the discussion.
-
Good 'Supplier Hygiene' Before And After COVID And The BIOSECURE Act3/12/2025
Can you recall the fundamentals of outsourcing development and manufacturing five or 10 years ago, if you were in the industry then? Our panel can, and it’s instructive to take the trip back in time.
DRUG DEVELOPMENT SOLUTIONS
-
Can your product be NanoImproved? Find out at at-a-glance with a 4-page informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.
-
Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.
-
Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.
-
Inspired by excellence and empowered by people, explore how inSeption Group is able to work as a full-service outsourcing solution to meet and exceed study expectations.
-
We offer a comprehensive suite of bioanalytical and spatial biology solutions designed to support the progression of your molecule from discovery through clinical development and product approval.